
Bioorganic and Medicinal Chemistry Letters p. 1649 - 1654 (1998)
Update date:2022-08-03
Topics:
Hoekstra, William J.
Hulshizer, Becky L.
McComsey, David F.
Andrade-Gordon, Patricia
Kauffman, Jack A.
Addo, Michael F.
Oksenberg, Donna
Scarborough, Robert M.
Maryanoff, Bruce E.
The thrombin receptor (PAR-1) is activated by α-thrombin to stimulate various cell types, including platelets, through the tethered-ligand sequence SFLLRN. A series of azole-based carboxamides, designed after SFLLR, were synthesized and evaluated in vitro. The compounds inhibited platelet aggregation induced by SFLLRN-NH2 or α-thrombin, and blocked the binding of [3H]-S-(p-F-Phe)-Har-L-Har-KY-NH2 to a CHRF membrane preparation of PAR-1. Oxazole 30 bound to PAR-1 with an IC50 of 1.6 μM, and gave IC50 values of 25 μM and 6.6 μM against α-thrombin- and SFLLRN-NH2-induced platelet aggregation, respectively.
View Morewebsite:http://www.apeptides.com/en/
Contact:+86-21-60871011
Address:No. 80 Chuanshan Shuyuan Steet,Pudong,Shanghai
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
Contact:+86-25-52346955
Address:199,JIANYE ROAD,NANJING,CHINA
Contact:+1-284-4950244
Address:Box 3069, Road Town, Tortola, British Virgin Islands
Doi:10.1134/S0022476611030280
(2011)Doi:10.1246/cl.1980.425
(1980)Doi:10.1021/acs.joc.0c00279
(2020)Doi:10.1021/jm00131a012
(1989)Doi:10.1080/10426500802705537
(2009)Doi:10.1016/j.saa.2009.11.022
(2010)